Home
Scholarly Works
Use of erythropoietins in patients with renal...
Journal article
Use of erythropoietins in patients with renal transplants
Abstract
Normalisation of haemoglobin is hazardous, ineffective, and costly
Authors
Treleaven DJ; Clase CM
Journal
The BMJ, Vol. 339, No. oct23 1,
Publisher
BMJ
Publication Date
October 23, 2009
DOI
10.1136/bmj.b3825
ISSN
0959-8138
Associated Experts
Catherine Clase
Professor, FHSMED
Visit profile
Darin Treleaven
Associate Professor, FHSMED
Visit profile
Labels
Fields of Research (FoR)
32 Biomedical and clinical sciences
3202 Clinical Sciences
42 Health sciences
52 Psychology
Sustainable Development Goals (SDG)
3 Good Health and Well Being
Medical Subject Headings (MeSH)
Anemia
Chronic Disease
Erythropoietin
Hematinics
Hemoglobins
Humans
Kidney Diseases
Kidney Transplantation
Meta-Analysis as Topic
Quality of Life
Randomized Controlled Trials as Topic
Recombinant Proteins
View published work (Non-McMaster Users)
View published work (McMaster Users)
Scholarly citations from Dimensions
Contact the Experts team
Get technical help
or
Provide website feedback